Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Visceral analgesics: drugs with a great potential in functional disorders?

Bradesi S, Herman J, Mayer EA.

Curr Opin Pharmacol. 2008 Dec;8(6):697-703. doi: 10.1016/j.coph.2008.08.009. Epub 2008 Sep 26. Review.

PMID:
18786654
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.

Elsenbruch S.

Brain Behav Immun. 2011 Mar;25(3):386-94. doi: 10.1016/j.bbi.2010.11.010. Epub 2010 Nov 20. Review.

PMID:
21094682
[PubMed - indexed for MEDLINE]
3.

The role of experimental models in developing new treatments for irritable bowel syndrome.

Holschneider DP, Bradesi S, Mayer EA.

Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):43-57. doi: 10.1586/egh.10.88. Review.

PMID:
21309671
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].

Makarchuk PA.

Eksp Klin Gastroenterol. 2007;(6):126-9. Russian. No abstract available.

PMID:
18418922
[PubMed - indexed for MEDLINE]
5.

Visceral hypersensitivity in irritable bowel syndrome.

Kanazawa M, Hongo M, Fukudo S.

J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:119-21. doi: 10.1111/j.1440-1746.2011.06640.x.

PMID:
21443723
[PubMed - indexed for MEDLINE]
6.

Partially hydrolyzed guar gum in pediatric functional abdominal pain.

Romano C, Comito D, Famiani A, CalamarĂ  S, Loddo I.

World J Gastroenterol. 2013 Jan 14;19(2):235-40. doi: 10.3748/wjg.v19.i2.235.

PMID:
23345946
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.

Klooker TK, Leliefeld KE, Van Den Wijngaard RM, Boeckxstaens GE.

Neurogastroenterol Motil. 2011 Jan;23(1):30-5, e2. doi: 10.1111/j.1365-2982.2010.01587.x. Epub 2010 Aug 16.

PMID:
20718944
[PubMed - indexed for MEDLINE]
8.

Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.

Naliboff BD, Berman S, Suyenobu B, Labus JS, Chang L, Stains J, Mandelkern MA, Mayer EA.

Gastroenterology. 2006 Aug;131(2):352-65.

PMID:
16890589
[PubMed - indexed for MEDLINE]
9.

Visceral hyperalgesia in children with functional abdominal pain.

Di Lorenzo C, Youssef NN, Sigurdsson L, Scharff L, Griffiths J, Wald A.

J Pediatr. 2001 Dec;139(6):838-43.

PMID:
11743510
[PubMed - indexed for MEDLINE]
10.

Achieving translation in models of visceral pain.

Bulmer DC, Grundy D.

Curr Opin Pharmacol. 2011 Dec;11(6):575-81. doi: 10.1016/j.coph.2011.09.008. Epub 2011 Oct 13. Review.

PMID:
22000605
[PubMed - indexed for MEDLINE]
11.

Placebo effect in patients with irritable bowel syndrome.

Lu CL, Chang FY.

J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:116-8.

PMID:
21751434
[PubMed - indexed for MEDLINE]
12.

Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome.

Tjong Y, Ip S, Lao L, Fong HH, Sung JJ, Berman B, Che C.

J Ethnopharmacol. 2011 Jun 1;135(3):754-61. doi: 10.1016/j.jep.2011.04.007. Epub 2011 Apr 12.

PMID:
21511022
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients.

Verne GN, Robinson ME, Vase L, Price DD.

Pain. 2003 Sep;105(1-2):223-30.

PMID:
14499439
[PubMed - indexed for MEDLINE]
14.

Irritable bowel syndrome: toward an understanding of severity.

Lembo A, Ameen VZ, Drossman DA.

Clin Gastroenterol Hepatol. 2005 Aug;3(8):717-25. Review.

PMID:
16233998
[PubMed - indexed for MEDLINE]
15.

Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation.

Blackshaw LA, Brierley SM.

Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5 Suppl 1):15-9. doi: 10.1586/17474124.2013.820045. Review.

PMID:
23859756
[PubMed - indexed for MEDLINE]
16.

Visceral sensation and irritable bowel syndrome; with special reference to comparison with functional abdominal pain syndrome.

Nozu T, Okumura T.

J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:122-7. doi: 10.1111/j.1440-1746.2011.06636.x.

PMID:
21443724
[PubMed - indexed for MEDLINE]
17.

How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?

Tack J.

Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5 Suppl 1):21-6. doi: 10.1586/17474124.2013.820046. Review.

PMID:
23859757
[PubMed - indexed for MEDLINE]
18.

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.

Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J; OBIS Study Investigators.

Aliment Pharmacol Ther. 2011 Aug;34(4):432-42. doi: 10.1111/j.1365-2036.2011.04730.x. Epub 2011 Jun 16.

PMID:
21679214
[PubMed - indexed for MEDLINE]
19.

[Rectal barostat in irritable bowel syndrome].

Defilippi G C, Quera P R, Madrid S AM, Defilippi C C, Valenzuela E J.

Rev Med Chil. 2006 Dec;134(12):1524-9. Epub 2007 Jan 24. Spanish.

PMID:
17277868
[PubMed - indexed for MEDLINE]
Free Article
20.

Novel therapeutic approaches in IBS.

Bradesi S, Mayer EA.

Curr Opin Pharmacol. 2007 Dec;7(6):598-604. Epub 2007 Nov 19. Review.

PMID:
18006379
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk